A European perspective on social anxiety disorder

被引:88
作者
Lecrubier, Y [1 ]
Wittchen, HU
Faravelli, C
Bobes, J
Patel, A
Knapp, M
机构
[1] Hop La Pitie Salpetriere, INSERM, Paris, France
[2] Max Planck Inst Psychiat Clin Psychol & Epidemiol, Munich, Germany
[3] Univ Florence, Dept Neurol & Psychiat Sci, Florence, Italy
[4] Serv Psiquiatria, Fac Med, Oviedo, Spain
[5] Inst Psychiat, Ctr Econ Mental Hlth, London, England
关键词
co-morbidity; disability; Europe; prevalence; social anxiety disorder; socioeconomic;
D O I
10.1016/S0924-9338(00)00216-9
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Epidemiologic surveys conducted across Europe indicate that the lifetime prevalence of social anxiety disorder in the general population is close to 7%. The disorder in adulthood rarely presents in its 'pure' form and 70-80% of patients have at least one other psychiatric disorder, most commonly depression. Social anxiety disorder is a risk factor for the development of depression and alcohol/substance use or dependence, especially in cases with an early onset (< 15 years). Individuals with social anxiety disorder have significant functional impairment, notably in the areas of initiation and maintenance of social/romantic relationships and educational and work achievement. The economic consequences of social anxiety disorder are considerable, with a high level of diminished work productivity, unemployment and an increased utilisation of medical services amongst sufferers. Effective treatment of social anxiety disorder would improve its course and its health and economic consequences. (C) 2000 Editions scientifiques et medicales Elsevier SAS.
引用
收藏
页码:5 / 16
页数:12
相关论文
共 46 条
[1]  
ANGST J, 1992, SALUD MENT, V15, P1
[2]  
ANGST J, 1995, EUR ARCH PSY NEUR SC, V235, P171
[3]  
ARILLO A, 1998, ATEN PRIMARIA, V21, P5
[4]  
ASPENDORF JB, 1989, J PERS SOC PSYCHOL, V57, P481
[5]  
Ballenger JC, 1998, J CLIN PSYCHIAT, V59, P54
[6]   Prevalence of psychiatric disorder in the general population: results of the Netherlands Mental Health Survey and Incidence Study (NEMESIS) [J].
Bijl, RV ;
Ravelli, A ;
van Zessen, G .
SOCIAL PSYCHIATRY AND PSYCHIATRIC EPIDEMIOLOGY, 1998, 33 (12) :587-595
[7]   Social phobia in primary care: Level of recognition and drug use [J].
Bisserbe, JC ;
Weiller, E ;
Boyer, P ;
Lepine, JP ;
Lecrubier, Y .
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 1996, 11 :25-28
[8]  
Bobes J, 1999, MED CLIN-BARCELONA, V112, P530
[9]   The efficacy of 2 different dosages of methylphenidate in treating adults with attention-deficit hyperactivity disorder [J].
Bouffard, R ;
Hechtman, L ;
Minde, K ;
Iaboni-Kassab, F .
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2003, 48 (08) :546-554
[10]   PHOBIA - PREVALENCE AND RISK-FACTORS [J].
BOYD, JH ;
RAE, DS ;
THOMPSON, JW ;
BURNS, BJ ;
BOURDON, K ;
LOCKE, BZ ;
REGIER, DA .
SOCIAL PSYCHIATRY AND PSYCHIATRIC EPIDEMIOLOGY, 1990, 25 (06) :314-323